Misbah Tahir
2019
In 2019, Misbah Tahir earned a total compensation of $589K as Chief Financial Officer at IGM Biosciences.
Compensation breakdown
| Non-Equity Incentive Plan | $117,600 |
|---|---|
| Option Awards | $121,379 |
| Salary | $350,000 |
| Total | $588,979 |
Tahir received $350K in salary, accounting for 59% of the total pay in 2019.
Tahir also received $117.6K in non-equity incentive plan and $121.4K in option awards.
Rankings
In 2019, Misbah Tahir's compensation ranked 11,270th out of 13,971 executives tracked by ExecPay. In other words, Tahir earned more than 19.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,270 out of 13,971 | 19th |
Division Manufacturing | 4,566 out of 5,701 | 20th |
Major group Chemicals And Allied Products | 1,797 out of 2,200 | 18th |
Industry group Drugs | 1,545 out of 1,886 | 18th |
Industry Pharmaceutical Preparations | 1,144 out of 1,398 | 18th |
Source: SEC filing on July 6, 2020.
Tahir's colleagues
We found two more compensation records of executives who worked with Misbah Tahir at IGM Biosciences in 2019.